Skip to main content

Table 2 Study characteristics

From: Screening for sickle cell disease in newborns: a systematic review

Study

Study design

Investigated newborns (intervention/control)

Number of newborns with SCD

Place and period of recruitment

Intervention/control

Main inclusion criteria

Patient-relevant endpoints

Funding source

King et al. [26]

Retrospective controlled cohort study

Intervention group:

150,803

435a (SCD-S/S)

Jamaica

Victoria Jubilee Hospital, Kingston, 11/1995–07/2006

University Hospital of the West Indies, Kingston, 10/1997–07/2006

Spanish Town Hospital, St. Catherine, 04/1998–07/2006

- Screening of live newborns for SCD

- In the case of diagnosis of an SCD initial consultation and education programme

- If possible, parents will receive a newborn first consultation at the clinic before the 4th month of life

- Guidance of the parents on how to perform a splenic palpation

- From the 4th month of life penicillin prophylaxis

- Every 3 months routine examination in clinic, every 6 months after 5 years of age

- Consecutive live newborns

- Screening of umbilical cord blood indicates SCD-S/S phenotype

- Confirmation diagnostics confirmed SCD-S/S (electrophoresis)

Mortality in 1st, 2nd, 3rd, 5th, and 10th year of lifeb

Not stated

  

Control groupc:

approx. 30,000

105 (SCD-S/S)

Jamaica

Victoria Jubilee Hospital, Kingston, 06/1973–12/1975

-Screening of all live newborns for SCD

-Follow-up every 3 months

   
  1. SCD-S/S homozygous sickle cell disease
  2. aParents of 40 of the 435 newborns did not attend the initial consultation. Therefore, 395 newborns were included in the intervention programme
  3. bOther reported patient-relevant endpoints (hospitalisations, “serious illness”, and invasive pneumococcal disease) were not considered, as their operationalisations were unusable
  4. cFirst subpopulation of the birth cohort 06/1973–12/1981 (N = 100,000) of Victoria Jubilee Hospital, Kingston, Jamaica. The second (recruitment: 12/1975–01/1979) and third subpopulations (recruitment: 01/1979–12/1981) are not presented in the report because in these subpopulations the diagnosis of SCD was associated with secondary preventive measures; see Lee 1995 [25]